2-Chloroadenosine 5-triphosphate (sodium salt)
(Synonyms: 2-chloro ATP) 目录号 : GC49718
An adenine nucleotide and ATP analog
Cas No.:301334-89-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
2-Chloroadenosine 5-triphosphate (2-chloro ATP) is an adenine nucleotide and analog of ATP .1,2 It is an antagonist of the purinergic P2Y1 receptor, inhibiting intracellular calcium mobilization induced by ADP in Jurkat cells expressing the human receptor (Ki = 2.3 µM).3 2-chloro ATP is an agonist of purinergic P2X receptors, inducing inward currents in HEK293 cells expressing the human bladder smooth muscle or rat PC12 forms of the receptor (EC50s = 0.5 and 2.5 µM, respectively).4 It induces relaxation of precontracted isolated guinea pig taenia caeci strips in a concentration-dependent manner.1 It has been used to study the substrate specificity of cyclic nucleotide-dependent protein kinases, such as protein kinase A (PKA) and PKG.2
1.Satchell, G., and Maguire, M.H.Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coliJ. Pharmacol. Exp. Ther.195(3)540-548(1975) 2.Flockhart, D.A., Freist, W., Hoppe, J.O., et al.ATP analog specificity of CAMP-dependent protein kinase, cGMP-dependent protein kinase, and phosphorylase kinaseEur. J. Biochem.140(2)289-295(1984) 3.Hechler, B., Vigne, P., LÉon, C., et al.ATP derivatives are antagonists of the P2Y1 receptor: Similarities to the platelet ADP receptorMol. Pharmacol.53(4)727-733(1997) 4.Evans, R.J., Lewis, C., Buell, G., et al.Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors)Mol. Pharmacol.48(2)178-183(1995)
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.5883 mL | 7.9416 mL | 15.8831 mL |
| 5 mM | 0.3177 mL | 1.5883 mL | 3.1766 mL |
| 10 mM | 0.1588 mL | 0.7942 mL | 1.5883 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。